Open navigation menu
Close suggestions
Search
Search
en
Change Language
Upload
Loading...
Loading...
User Settings
close menu
Welcome to Scribd!
Upload
Read for free
FAQ and support
Language (EN)
Sign in
0 ratings
0% found this document useful (0 votes)
142 views
Feasibility Study Obat Tradisional Molex Ayus
Uploaded by
Bambang Priyambodo
feasibility study
Copyright:
© All Rights Reserved
Available Formats
Download
as PDF or read online from Scribd
Download
Save
Save Feasibility Study Obat Tradisional Molex Ayus For Later
0%
0% found this document useful, undefined
0%
, undefined
Embed
Share
Print
Report
Feasibility Study Obat Tradisional Molex Ayus
Uploaded by
Bambang Priyambodo
0 ratings
0% found this document useful (0 votes)
142 views
15 pages
Document Information
click to expand document information
feasibility study
Copyright
© © All Rights Reserved
Available Formats
PDF or read online from Scribd
Share this document
Share or Embed Document
Sharing Options
Share on Facebook, opens a new window
Facebook
Share on Twitter, opens a new window
Twitter
Share on LinkedIn, opens a new window
LinkedIn
Share with Email, opens mail client
Email
Copy link
Copy link
Did you find this document useful?
0%
0% found this document useful, Mark this document as useful
0%
0% found this document not useful, Mark this document as not useful
Is this content inappropriate?
Report
feasibility study
Copyright:
© All Rights Reserved
Available Formats
Download
as PDF or read online from Scribd
Download now
Download as pdf
Save
Save Feasibility Study Obat Tradisional Molex Ayus For Later
0 ratings
0% found this document useful (0 votes)
142 views
15 pages
Feasibility Study Obat Tradisional Molex Ayus
Uploaded by
Bambang Priyambodo
feasibility study
Copyright:
© All Rights Reserved
Available Formats
Download
as PDF or read online from Scribd
Save
Save Feasibility Study Obat Tradisional Molex Ayus For Later
0%
0% found this document useful, undefined
0%
, undefined
Embed
Share
Print
Report
Download now
Download as pdf
Jump to Page
You are on page 1
of 15
Search inside document
Prospek Pengembangan Obat Tradisicnal Perusahaan Farmasi Skala Kecil Menengah (Kasus PT. Molex Ayus Pharmaceutical) Richtiarty Superani*, Musa Hubeis* dan Budi Purwanto” Abstract Traditional medicine is one of Indonesia's natural resources which has been used for many years by Indonesians, and which has also helped them to solve many health problems, and cultivate (ndonesia's natural resources. PT Molex Ayus Pharmaceutical (MAP) is a middle scale pharmaceutical company that is trying to develop its business by running the traditional medicine industry _ The purpose of this study is to know and analyze the prospect or opportunity of the development of traditional medicine of the small to medium scale pharmaceutical companies which in this case it is PT MAP. Therefore, there have been collecting data through library studies, visiting sites, observing directty, and interviewing related individuals. To obtain the right solution, the company uses Strengths, ‘Weaknesses, Opportunities and Threats (SWOT) descriptive-qualitative analysis to observe the internals (strengths, weaknesses) and external (opportunities, threats), in order to support the next step in conducting the project. The methods of Net Present Value (NPV), Intemal Rate of Return (IRR), Payback Period (PBP), and Profitability Index (Pl) are used in calculating the analysis of the feasibility of investment (investment analysis), The result of the study shows that the prospect of traditional medicine industries is stil wide open, and from the analysis above it is found that it is feasible enough to conduct this project, with the sales assumption of up to 5% per year, NPV Rp. 39,148,158,00 (positive), IRR 23.41% higher than the commercial interest which is at 15% at the moment, PBP 4 years and 8 months, and Pl 1.33. From the SWOT analysis, 14 alternative strategies can be chosen by the company to improve its performance, get the right market, put the right man in the right place, in order to increase teamwork and efficiency of production cost. Keywords : Traditional medicine, PT. MAP, SWOT, feasibility of investment PENDAHULUAN 1. Latar Belakang Indonesia memiliki kekayaan sumber daya alam (SDA) yang sangat melimpah, obat-obatan tradisional yang berbahan baku tanaman obat merupakan salah satu cara pemanfaatan kekayaan alam yang digunakan masyarakat di Indonesia untuk meningkatkan nilal tambah SDA, serta untuk memberikan solusi pada permasalahan-permasalahan kesehatan yang dihadapinya (PT. CIC, 2001). Obat tradisional yang selama ini dikenal, merupakan produk yang dikenal sebagai jamu, berupa bubuk ramuan ataupun cairan hasil dari rebusan temu-ramuan dari bahan-bahan tumbuhan alam (tanaman obat), yang cara produksi maupun formulasinya menggunakan carafformulasi yang sudah ada secara turun temurun. Formulasi dari tumbuh-tumbuhan alam saat ini diekstrak dan diproduksi berdasarkan penelitian dari imuwan-ilmuwan dan dikemas dengan teknologi mutakhir dalam bentuk yang menarik, rasa ataupun Khasiat yang lebih spesifik, serta mudah dalam cara pemakaiannya indonesia merupakan negara di Association South-East Asian Nation (ASEAN) yang paling kaya akan tanaman obat, dari sekitar 1,000 tanaman obat yang tumbuh di indonesia baru sekitar 200 tanamen yang dimanfaatkan untuk obat tradisional. Pemerintah saat ini bersama Negara-negara ASEAN juga sedang membahas Hatmonisasi Standardisasi Obat Tradisional dan Makanan Suplemen se ASEAN (Media Indonesia, 2004), yang akan berdampak pada besamya peluang pasar yang akan didapat, sehingga industri obet tradisional ini jelas merupakan industri yang masih sangat berpeluang. Industri jamu di Indonesia terdiri dari 75 industri besar (industri obat tradisional atau |OT) dan 833, industri kecil (Industri Kecil Obat Tradisional atau IKOT) dimana pada sektor produksi ini diserap sekitar 145.000 orang tenaga kerja, meliputi 37.529 pekerja di OT dan 107.622 pekerja di {KOT dari berbagallapisan pendidikan, sedangkan sektr ditibusinya metibatkan 400,000 orang (Sihombing, 2004). * alumni PS MPI, SPs IPB. ? staf Pengajar PS MPI, SPs IPB85 PT. Molex Ayus Pharmaceutical (PT. MAP) yang bergerek di bidang farmasi dengan produk obat-obatan berbahan baku kiria ‘sintetik, tertarik dengan prospek pengembangan industri obat tradisionai, Pada saat ini, dengan tingginya tingkat kesadaran akan pentingnya kesehatan masyarakat dan diketahuinya efek yang dinadapi dari pemakaian obat-obat modem berbahan baku sintetik serta semakin berkembangnya kesadaran masyarakat untuk back fo nature telah menyebabkan obat-obat tradisional mendapatkan tempat yang cukup baik. Dibandingkan dengan obat-obat berbahan baku kimia, obat tradisional dalam industri memiliki berbagai Kendala, diantaranya tidak adanya sistem baku dalam pengobatannya dan belum banyak diakuinya produk obat tradisionat dalam sistem pengobatan kedokteran modern di Indonesia (Rahayuningsih, 2004). 2. Permasalahan Permasalahan dalam useha adalah suatu hambatan atau kendala yang adaltimbul dalam suatu perjalanandusaha yang merupakan sual proses atau tingkatan yang harus ditalui untuk menuju hasil akhir yang sesvai dengan tujuan/keinginan perusahaan/sekelompok orang yang mempunyai kepentingan sama. Saizh satu cara dalam memperoleh gambaran solusi adalah menganalisa permasalahan-permasalahan yang diajukan ditinjau dari segala aspek yang terkait, baik internal maupun eksternal. Hasil analisa tersebut dapat merupakan bahan masukan bagi perusahaan, khususnya dalam mengembangkan obat tradisional untuk pengobatan kesehatan masyarakat luas bagi perusatean PT. MAP dan metupakan bahan masukan dalam mengembangken bisnis perusahaan melalui pengembangan produk pada industri obat tradisional. Permasalahan pada kajian ini dapat ditumuskan sebagai berikut : a. Bagaimana solusi dari permasalahan yang dihadapi perusahaan (PT. MAP), yang juga merupakan permasalahan yang dihadapi oleh petusahaan farmasi skala menengah, untuk mewujudkan tujuannya, dengan cara mengkaji kondisi internal dan ekstemal perusahan, serta_strategi pemasaran yang sudah/dapat dijalankan perusahaan bagi produksi abatabat tradisional 2 b. Bagaimana pemahaman lebih jauh tentang produksi obat tradisional yang dihasitkan perusahaan farmasi seperti PT. MAP, sebagai praduk UKM yang potensial dan sebagai pengganti/pelengkap memiliki daya saing terhadap obat berbahan baku kimia sintetis sebagai salah satu sumber pengobatan kesehatan bagi masyarakat di indonesia? ©. Bagaimana nilai kelayakan investasi dalam pertambahan investasi, bagi pengembangan pperusehean (PT. MAP) yang merupakan suatu perusahaan {armasi skala kecil menengah dengan berbasis pada produk obat tradisional ? 3. Tujuan Tujuan dari hal yang dikaji adalah : a. Mendapatkan solusi dari permasalahan yang dihadapi perusahaan (PT. MAP), yang juga merupakan permasalahan yang dihadapi oleh perusahaan farmasi skala menengah, untuk mewujudkan tujuannya, dengan cara mengkaji kondisi intemal dan ekstemal perusahan, serta strategi pemasaran yang sudah/dapat dijalankan perusahaan bagi produksi obat-obat tradisional b. Mendapatkan pemahaman lebih jauh tentang produksi obat tradisional yang dihasilkan perusahaan farmasi seperti PT. MAP, sebagai produk UKM yang potensial dan sebagai penggenti/pelengkap memiliki daya saing tethadap obat berbahan baku kimia sintetis sebagai salah satu sumber pengobatan kesehatan bagi masyarakat di Indonesia. ©. Mengevaluasi_nilai Kelayakan investasi dalam pertambahan investasi, bagi pengembangan perusahaan (PT. MAP) yang merupakan suatu perusahaan farmasi skala kecil menengah dengan berbasis pada produk obat tradisional. 1. Lokasi Kajian ini merupakan studi kasus di PT. Molex Ayus yang merupakan perusahaan farmasi swasta yang berdiri pada tanggal 23 Agustus 1985 dan beralamatkan di Gedung Molex Ayus, J. Ir H Juanda No. § C, Jakarta Pusat 10120. 2 Metade Kerja Pengumpulan data - Pengumpulan data berupa data primer dan sekunder, Data primer bersumber dari hasit kunjungan dan observasi lapangan berupa wawancara kepada staf-stef perusahaan ataupun individu-
You might also like
The Subtle Art of Not Giving a F*ck: A Counterintuitive Approach to Living a Good Life
From Everand
The Subtle Art of Not Giving a F*ck: A Counterintuitive Approach to Living a Good Life
Mark Manson
Rating: 4 out of 5 stars
4/5 (5912)
The Gifts of Imperfection: Let Go of Who You Think You're Supposed to Be and Embrace Who You Are
From Everand
The Gifts of Imperfection: Let Go of Who You Think You're Supposed to Be and Embrace Who You Are
Brené Brown
Rating: 4 out of 5 stars
4/5 (1103)
Principles: Life and Work
From Everand
Principles: Life and Work
Ray Dalio
Rating: 4 out of 5 stars
4/5 (617)
Never Split the Difference: Negotiating As If Your Life Depended On It
From Everand
Never Split the Difference: Negotiating As If Your Life Depended On It
Chris Voss
Rating: 4.5 out of 5 stars
4.5/5 (874)
The Glass Castle: A Memoir
From Everand
The Glass Castle: A Memoir
Jeannette Walls
Rating: 4.5 out of 5 stars
4.5/5 (1732)
Sing, Unburied, Sing: A Novel
From Everand
Sing, Unburied, Sing: A Novel
Jesmyn Ward
Rating: 4 out of 5 stars
4/5 (1216)
Hidden Figures: The American Dream and the Untold Story of the Black Women Mathematicians Who Helped Win the Space Race
From Everand
Hidden Figures: The American Dream and the Untold Story of the Black Women Mathematicians Who Helped Win the Space Race
Margot Lee Shetterly
Rating: 4 out of 5 stars
4/5 (918)
Grit: The Power of Passion and Perseverance
From Everand
Grit: The Power of Passion and Perseverance
Angela Duckworth
Rating: 4 out of 5 stars
4/5 (597)
Shoe Dog: A Memoir by the Creator of Nike
From Everand
Shoe Dog: A Memoir by the Creator of Nike
Phil Knight
Rating: 4.5 out of 5 stars
4.5/5 (543)
The Perks of Being a Wallflower
From Everand
The Perks of Being a Wallflower
Stephen Chbosky
Rating: 4.5 out of 5 stars
4.5/5 (2109)
The Hard Thing About Hard Things: Building a Business When There Are No Easy Answers
From Everand
The Hard Thing About Hard Things: Building a Business When There Are No Easy Answers
Ben Horowitz
Rating: 4.5 out of 5 stars
4.5/5 (352)
Elon Musk: Tesla, SpaceX, and the Quest for a Fantastic Future
From Everand
Elon Musk: Tesla, SpaceX, and the Quest for a Fantastic Future
Ashlee Vance
Rating: 4.5 out of 5 stars
4.5/5 (475)
Her Body and Other Parties: Stories
From Everand
Her Body and Other Parties: Stories
Carmen Maria Machado
Rating: 4 out of 5 stars
4/5 (830)
Bad Feminist: Essays
From Everand
Bad Feminist: Essays
Roxane Gay
Rating: 4 out of 5 stars
4/5 (1044)
The Outsider: A Novel
From Everand
The Outsider: A Novel
Stephen King
Rating: 4 out of 5 stars
4/5 (1920)
The Emperor of All Maladies: A Biography of Cancer
From Everand
The Emperor of All Maladies: A Biography of Cancer
Siddhartha Mukherjee
Rating: 4.5 out of 5 stars
4.5/5 (273)
The Little Book of Hygge: Danish Secrets to Happy Living
From Everand
The Little Book of Hygge: Danish Secrets to Happy Living
Meik Wiking
Rating: 3.5 out of 5 stars
3.5/5 (418)
Steve Jobs
From Everand
Steve Jobs
Walter Isaacson
Rating: 4.5 out of 5 stars
4.5/5 (812)
Angela's Ashes: A Memoir
From Everand
Angela's Ashes: A Memoir
Frank McCourt
Rating: 4.5 out of 5 stars
4.5/5 (443)
A Man Called Ove: A Novel
From Everand
A Man Called Ove: A Novel
Fredrik Backman
Rating: 4.5 out of 5 stars
4.5/5 (4849)
Brooklyn: A Novel
From Everand
Brooklyn: A Novel
Colm Toibin
Rating: 3.5 out of 5 stars
3.5/5 (1958)
The Yellow House: A Memoir (2019 National Book Award Winner)
From Everand
The Yellow House: A Memoir (2019 National Book Award Winner)
Sarah M. Broom
Rating: 4 out of 5 stars
4/5 (99)
The World Is Flat 3.0: A Brief History of the Twenty-first Century
From Everand
The World Is Flat 3.0: A Brief History of the Twenty-first Century
Thomas L. Friedman
Rating: 3.5 out of 5 stars
3.5/5 (2270)
The Sympathizer: A Novel (Pulitzer Prize for Fiction)
From Everand
The Sympathizer: A Novel (Pulitzer Prize for Fiction)
Viet Thanh Nguyen
Rating: 4.5 out of 5 stars
4.5/5 (122)
Devil in the Grove: Thurgood Marshall, the Groveland Boys, and the Dawn of a New America
From Everand
Devil in the Grove: Thurgood Marshall, the Groveland Boys, and the Dawn of a New America
Gilbert King
Rating: 4.5 out of 5 stars
4.5/5 (269)
Yes Please
From Everand
Yes Please
Amy Poehler
Rating: 4 out of 5 stars
4/5 (1929)
The Art of Racing in the Rain: A Novel
From Everand
The Art of Racing in the Rain: A Novel
Garth Stein
Rating: 4 out of 5 stars
4/5 (4240)
A Tree Grows in Brooklyn
From Everand
A Tree Grows in Brooklyn
Betty Smith
Rating: 4.5 out of 5 stars
4.5/5 (1933)
The Woman in Cabin 10
From Everand
The Woman in Cabin 10
Ruth Ware
Rating: 3.5 out of 5 stars
3.5/5 (2564)
Team of Rivals: The Political Genius of Abraham Lincoln
From Everand
Team of Rivals: The Political Genius of Abraham Lincoln
Doris Kearns Goodwin
Rating: 4.5 out of 5 stars
4.5/5 (235)
A Heartbreaking Work Of Staggering Genius: A Memoir Based on a True Story
From Everand
A Heartbreaking Work Of Staggering Genius: A Memoir Based on a True Story
Dave Eggers
Rating: 3.5 out of 5 stars
3.5/5 (232)
Wolf Hall: A Novel
From Everand
Wolf Hall: A Novel
Hilary Mantel
Rating: 4 out of 5 stars
4/5 (4004)
Fear: Trump in the White House
From Everand
Fear: Trump in the White House
Bob Woodward
Rating: 3.5 out of 5 stars
3.5/5 (802)
John Adams
From Everand
John Adams
David McCullough
Rating: 4.5 out of 5 stars
4.5/5 (2410)
Rise of ISIS: A Threat We Can't Ignore
From Everand
Rise of ISIS: A Threat We Can't Ignore
Jay Sekulow
Rating: 3.5 out of 5 stars
3.5/5 (137)
On Fire: The (Burning) Case for a Green New Deal
From Everand
On Fire: The (Burning) Case for a Green New Deal
Naomi Klein
Rating: 4 out of 5 stars
4/5 (74)
The Light Between Oceans: A Novel
From Everand
The Light Between Oceans: A Novel
M.L. Stedman
Rating: 4.5 out of 5 stars
4.5/5 (789)
Manhattan Beach: A Novel
From Everand
Manhattan Beach: A Novel
Jennifer Egan
Rating: 3.5 out of 5 stars
3.5/5 (881)
The Constant Gardener: A Novel
From Everand
The Constant Gardener: A Novel
John le Carré
Rating: 3.5 out of 5 stars
3.5/5 (108)
Difference Between T Cells and B Cells: September 2017
Document
10 pages
Difference Between T Cells and B Cells: September 2017
Bambang Priyambodo
No ratings yet
The Unwinding: An Inner History of the New America
From Everand
The Unwinding: An Inner History of the New America
George Packer
Rating: 4 out of 5 stars
4/5 (45)
1 Full
Document
5 pages
1 Full
Bambang Priyambodo
No ratings yet
Original Communication Zinc and Immune Function: M Dardenne
Document
4 pages
Original Communication Zinc and Immune Function: M Dardenne
Bambang Priyambodo
No ratings yet
Coronavirus Flowchart English PDF
Document
1 page
Coronavirus Flowchart English PDF
Bambang Priyambodo
No ratings yet
PRAKTISI IF - Inovasi Produk Dan Daya Saing Industri Farmasi Rev
Document
45 pages
PRAKTISI IF - Inovasi Produk Dan Daya Saing Industri Farmasi Rev
Bambang Priyambodo
No ratings yet
ONO PHARMACEUTICAL CO., LTD. and Bristol-Myers Squibb Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan
Document
5 pages
ONO PHARMACEUTICAL CO., LTD. and Bristol-Myers Squibb Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan
Bambang Priyambodo
No ratings yet
PQS Elemen - Management Review
Document
40 pages
PQS Elemen - Management Review
Bambang Priyambodo
100% (1)
ASEAN TMHS GMP Training Chapter 10 Self Inspection FD 28 Nov 2016 1
Document
31 pages
ASEAN TMHS GMP Training Chapter 10 Self Inspection FD 28 Nov 2016 1
Bambang Priyambodo
No ratings yet
Indonesia: Medicinal Plants of
Document
18 pages
Indonesia: Medicinal Plants of
Bambang Priyambodo
No ratings yet
PP Solo E-Reg 270917 - Fix
Document
82 pages
PP Solo E-Reg 270917 - Fix
Bambang Priyambodo
No ratings yet
ANNEX III ASEAN GL On Limits of Contaminations TMHS V1.0 (13nov14)
Document
11 pages
ANNEX III ASEAN GL On Limits of Contaminations TMHS V1.0 (13nov14)
Bambang Priyambodo
No ratings yet
CV
Document
2 pages
CV
Bambang Priyambodo
No ratings yet
Little Women
From Everand
Little Women
Louisa May Alcott
Rating: 4 out of 5 stars
4/5 (105)